Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Bioprinting & 3D-Printing in the Life Sciences EU 2018

Fabien Guillemot's Biography



Fabien Guillemot, Chief Executive Officer, Poietis

Dr. Fabien Guillemot is the CEO and founder of Poietis, company devoted to the fabrication of complex and customized tissues for regenerative medicine and pharmaceutical applications by Laser-Assisted Bioprinting. He obtained his PhD in Materials Science in 2000 from the National Institute for Applied Sciences (France) and was appointed Senior Researcher in 2005 at the National Institute for Health and Medical Research (INSERM, France). PI of the group Tissue Engineering Assisted by Laser, he accomplished pioneered works on in vivo and in situ bioprinting. In 2009, Dr. Guillemot organized the International Conference on Bioprinting and Biofabrication in Bordeaux. He is the author of more than 50 articles in peer-reviewed journals and about 40 invited conferences.

Fabien Guillemot Image

Skin Tissue Manufacturing Using Bio-Printing

Friday, 8 June 2018 at 13:00

Add to Calendar ▼2018-06-08 13:00:002018-06-08 14:00:00Europe/LondonSkin Tissue Manufacturing Using Bio-PrintingBioprinting and 3D-Printing in the Life Sciences EU 2018 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Bioprinting has been defined as “the use of computer-aided transfer processes for patterning and assembling living and non-living materials with a prescribed 2D or 3D organization in order to produce bio-engineered structures serving in regenerative medicine, pharmacokinetic and basic cell biology studies”.

From a technological point of view, several bioprinting technologies have been developed so far. Recently, Laser-Assisted Bioprinting (LAB) technology has emerged as an alternative method to inkjet and bioextrusion methods, thereby overcoming some of their limitations (namely clogging of print heads or capillaries) to pattern living cells and biomaterials with a micron-scale resolution and high cell viability.

During this presentation, we will present current development on the industrialization of bioprinting process, namely in the context of manufacturing 3D skin models.


Add to Calendar ▼2018-06-07 00:00:002018-06-08 00:00:00Europe/LondonBioprinting and 3D-Printing in the Life Sciences EU 2018Bioprinting and 3D-Printing in the Life Sciences EU 2018 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com